This page lists the SEC filings reported by Puissance Life Science Opportunities Fund VI.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2023-10-18 | Puissance Life Science Opportunities Fund VI | Bellerophon Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-10-17 | Puissance Life Science Opportunities Fund VI | Bellerophon Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-06-08 | Puissance Life Science Opportunities Fund VI | Bellerophon Therapeutics, Inc. | 1,076,841 | 10.3% | EDGAR |
| SC 13D/A | 2023-05-22 | Puissance Life Science Opportunities Fund VI | Bellerophon Therapeutics, Inc. | 1,211,262 | 11.6% | EDGAR |
| SC 13D/A | 2021-04-28 | Puissance Life Science Opportunities Fund VI | Bellerophon Therapeutics, Inc. | 1,763,077 | 18.6% | EDGAR |
| SC 13G/A | 2021-02-11 | Puissance Life Science Opportunities Fund VI | SCYNEXIS INC | 255,718 | 2.3% | EDGAR |
| SC 13D | 2020-05-22 | Puissance Life Science Opportunities Fund VI | Bellerophon Therapeutics, Inc. | 1,153,846 | 12.5% | EDGAR |
| SC 13G/A | 2020-02-14 | Puissance Life Science Opportunities Fund VI | SCYNEXIS INC | 126,865 | 0.0% | EDGAR |
| SC 13G | 2019-03-15 | Puissance Life Science Opportunities Fund VI | SCYNEXIS INC | 5,009,830 | 10.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.